O. S. Weislow

3.6k total citations · 1 hit paper
51 papers, 3.0k citations indexed

About

O. S. Weislow is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, O. S. Weislow has authored 51 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Virology, 20 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in O. S. Weislow's work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (17 papers) and Virus-based gene therapy research (9 papers). O. S. Weislow is often cited by papers focused on HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (17 papers) and Virus-based gene therapy research (9 papers). O. S. Weislow collaborates with scholars based in United States, Norway and Italy. O. S. Weislow's co-authors include Michael R. Boyd, John P. Bader, Rebecca Kiser, Robert H. Shoemaker, Donald L. Fine, James B. McMahon, Kirk R. Gustafson, John H. Cardellina, Bruce L. Levine and James L. Riley and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

O. S. Weislow

48 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity

1989 615 citations O. S. Weislow, Rebecca Kiser et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. S. Weislow United States	21	1.4k	1.1k	840	801	499	51	3.0k
Rob A. Gruters Netherlands	31	2.7k 1.9×	1.7k 1.5×	976 1.2×	1.7k 2.1×	780 1.6×	80	4.2k
Debashis Mitra India	31	753 0.5×	493 0.5×	1.1k 1.3×	956 1.2×	433 0.9×	99	2.8k
John P. Bader United States	33	873 0.6×	1.1k 1.0×	1.6k 1.9×	272 0.3×	512 1.0×	85	3.7k
Kenji Okonogi Japan	23	465 0.3×	685 0.6×	596 0.7×	379 0.5×	237 0.5×	54	1.9k
Eiichi Kodama Japan	35	2.0k 1.4×	2.3k 2.1×	1.4k 1.7×	362 0.5×	587 1.2×	139	4.0k
William M. Shannon United States	25	578 0.4×	925 0.8×	836 1.0×	148 0.2×	527 1.1×	75	2.1k
Mika Okamoto Japan	21	801 0.6×	661 0.6×	642 0.8×	573 0.7×	193 0.4×	65	2.0k
Amnon Hizi Israel	42	2.9k 2.0×	2.8k 2.6×	2.8k 3.3×	422 0.5×	665 1.3×	143	5.6k
Shan Cen China	39	1.8k 1.3×	1.7k 1.5×	2.4k 2.9×	1.1k 1.4×	1.0k 2.1×	214	5.2k
W. Gary Tarpley United States	28	1.5k 1.1×	1.5k 1.4×	1.2k 1.4×	153 0.2×	289 0.6×	57	2.9k

Countries citing papers authored by O. S. Weislow

Since Specialization

Citations

This map shows the geographic impact of O. S. Weislow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. S. Weislow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. S. Weislow more than expected).

Fields of papers citing papers by O. S. Weislow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. S. Weislow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. S. Weislow. The network helps show where O. S. Weislow may publish in the future.

Co-authorship network of co-authors of O. S. Weislow

This figure shows the co-authorship network connecting the top 25 collaborators of O. S. Weislow. A scholar is included among the top collaborators of O. S. Weislow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. S. Weislow. O. S. Weislow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wheelock, Ε. Frederick, Stephen T. Toy, O. S. Weislow, & Michael Levy. (2015). Restored Immune and Nonimmune Functions in Friend Virus Leukemic Mice Treated with Statolon1. Progress in tumor research. 19. 369–389.

Heberling, R. L., et al.. (2015). Isolation and Biological Properties of Endogenous Baboon (Papio cynocephalus) Type C Viruses1. Proceedings of the International Symposium on Comparative Leukemia Research. 158–160.

Burger, Richard M., et al.. (2001). Pre-clinical characterization of CTC-96 in a non-spermicidal topical virucide. AIDS. 15. S40–S40. 1 indexed citations

Conway, Brian, Valentina Montessori, Danielle Rouleau, et al.. (1999). Primary Lamivudine Resistance in Acute/Early Human Immunodeficiency Virus Infection. Clinical Infectious Diseases. 28(4). 910–911. 12 indexed citations

Mayers, Douglas L., James Bethel, M A Wainberg, O. S. Weislow, & Steven Schnittman. (1998). Human Immunodeficiency Virus Proviral DNA from Peripheral Blood and Lymph Nodes Demonstrates Concordant Resistance Mutations to Zidovudine (Codon 215) and Didanosine (Codon 74). The Journal of Infectious Diseases. 177(6). 1730–1733. 8 indexed citations

Riley, James L., Richard G. Carroll, Bruce L. Levine, et al.. (1997). Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. The Journal of Immunology. 158(11). 5545–5553. 68 indexed citations

Mascola, John R., S W Snyder, O. S. Weislow, et al.. (1996). Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 173(2). 340–348. 354 indexed citations

Buckheit, Robert W., Valerie Fliakas-Boltz, O. S. Weislow, et al.. (1995). Resistance to 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine Derivatives Is Generated by Mutations at Multiple Sites in the HIV-1 Reverse Transcriptase. Virology. 210(1). 186–193. 37 indexed citations

Cushman, Mark, W. Marek Gołębiewski, James B. McMahon, et al.. (1994). Design, Synthesis, and Biological Evaluation of Cosalane, a Novel Anti-HIV Agent Which Inhibits Multiple Features of Virus Reproduction. Journal of Medicinal Chemistry. 37(19). 3040–3050. 48 indexed citations

10.

Buckheit, Robert W., Melinda G. Hollingshead, E. Lucile White, et al.. (1993). Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Research. 21(3). 247–265. 86 indexed citations

11.

Gustafson, Kirk R., John H. Cardellina, James B. McMahon, et al.. (1992). A nonpromoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. Journal of Medicinal Chemistry. 35(11). 1978–1986. 162 indexed citations

12.

Hoffman, Paul M., Suhayl Dhib‐Jalbut, Judy A. Mikovits, et al.. (1992). Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.. Proceedings of the National Academy of Sciences. 89(24). 11784–11788. 89 indexed citations

13.

Clanton, David J., O. S. Weislow, Robert W. Buckheit, et al.. (1992). Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action.. PubMed. 5(8). 771–81. 25 indexed citations

14.

Clanton, David J., James B. McMahon, O. S. Weislow, et al.. (1992). Sulfonic Acid Dyes. 5(8). 771???781–771???781. 15 indexed citations

15.

McMahon, James B., et al.. (1990). Interactive Laser Cytometric Analysis of Retroviral Protein Expression in HIV-Infected Lymphocytic Cell Lines. AIDS Research and Human Retroviruses. 6(9). 1131–1137. 4 indexed citations

16.

Weinstein, John N., Barry Bunow, O. S. Weislow, et al.. (1990). Synergistic Drug Combinations in AIDS Therapy. Annals of the New York Academy of Sciences. 616(1). 367–384. 24 indexed citations

17.

Gustafson, Kirk R., John H. Cardellina, Richard W. Fuller, et al.. (1989). AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae). JNCI Journal of the National Cancer Institute. 81(16). 1254–1258. 210 indexed citations

18.

Vince, Robert, Hua Mei, Jay Brownell, et al.. (1988). Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitro. Biochemical and Biophysical Research Communications. 156(2). 1046–1053. 201 indexed citations

19.

Weislow, O. S., et al.. (1983). Partial Purification of a Placental Interferon with Atypical Characteristics. Journal of Interferon Research. 3(3). 291–298. 9 indexed citations

20.

Hellman, A., et al.. (1980). Abolition of Lymphocyte Blastogenesis by Oncornaviral Components. Advances in experimental medicine and biology. 121B. 99–109. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact